{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:16:34Z","timestamp":1791994594258,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFF1203005"],"award-info":[{"award-number":["2022YFF1203005"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["24ZR1491100"],"award-info":[{"award-number":["24ZR1491100"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22177068"],"award-info":[{"award-number":["22177068"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmech.2025.118113","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:36:39Z","timestamp":1756794999000},"page":"118113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Discovery of 2-tetrahydroisoquinoline substituted quinazoline derivatives as lysine methyltransferase G9a inhibitors with in vivo antitumor efficacy"],"prefix":"10.1016","volume":"300","author":[{"given":"Mengjie","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingfeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiting","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kailong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2379-8740","authenticated-orcid":false,"given":"Chunyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118113_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105865","article-title":"An update on allosteric modulators as a promising strategy targeting histone methyltransferase","volume":"172","author":"Tan","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2025.118113_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1021\/acs.chemrev.6b00801","article-title":"Inhibitors of protein methyltransferases and demethylases","volume":"118","author":"Kaniskan","year":"2018","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2025.118113_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1021\/acschembio.2c00062","article-title":"Exploring methods of targeting histone methyltransferases and their applications in cancer therapeutics","volume":"17","author":"Wang","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cbpa.2019.11.009","article-title":"Drugging histone methyltransferases in cancer","volume":"56","author":"Richart","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib5","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1101\/gad.989402","article-title":"G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis","volume":"16","author":"Tachibana","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.118113_bib6","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1038\/emboj.2008.192","article-title":"G9a\/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription","volume":"27","author":"Tachibana","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmech.2025.118113_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1101\/gad.1284005","article-title":"Histone methyltransferases G9a and GLP form heteromeric complexes and are both crucial for methylation of euchromatin at H3-K9","volume":"19","author":"Tachibana","year":"2005","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.118113_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.nlm.2015.06.013","article-title":"The role of chromatin repressive marks in cognition and disease: a focus on the repressive complex GLP\/G9a","volume":"124","author":"Benevento","year":"2015","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.ejmech.2025.118113_bib9","doi-asserted-by":"crossref","first-page":"9636","DOI":"10.1074\/jbc.M109.062588","article-title":"G9a and Glp methylate lysine 373 in the tumor suppressor p53","volume":"285","author":"Huang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.4161\/epi.23331","article-title":"G9a, a multipotent regulator of gene expression","volume":"8","author":"Shankar","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.ejmech.2025.118113_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nchembio.88","article-title":"Protein lysine methyltransferase G9a acts on non-histone targets","volume":"4","author":"Rathert","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib12","article-title":"G9a-mediated methylation of ER\u03b1 links the PHF20\/MOF histone acetyltransferase complex to hormonal gene expression","volume":"7","author":"Zhang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118113_bib13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/cr.2010.157","article-title":"Histone methyltransferase G9a contributes to H3K27 methylation in vivo","volume":"21","author":"Wu","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2025.118113_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.molcel.2012.01.019","article-title":"Histone H3 lysine 56 methylation regulates DNA replication through its interaction with PCNA","volume":"46","author":"Yu","year":"2012","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118113_bib15","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1172\/JCI69592","article-title":"Methyltransferase G9A regulates T cell differentiation during murine intestinal inflammation","volume":"124","author":"Antignano","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2025.118113_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.neuron.2009.11.019","article-title":"Control of cognition and adaptive behavior by the GLP\/G9a epigenetic suppressor complex","volume":"64","author":"Schaefer","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.ejmech.2025.118113_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1093\/brain\/awy354","article-title":"Inhibition of EHMT1\/2 rescues synaptic and cognitive functions for Alzheimer's disease","volume":"142","author":"Zheng","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.ejmech.2025.118113_bib18","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/nn.4165","article-title":"G9a is essential for epigenetic silencing of K+ channel genes in acute-to-chronic pain transition","volume":"18","author":"Laumet","year":"2015","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2025.118113_bib19","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nm.4257","article-title":"Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome","volume":"23","author":"Kim","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118113_bib20","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1476-4598-13-189","article-title":"The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis","volume":"13","author":"Hua","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2025.118113_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1158\/1541-7786.MCR-20-0557","article-title":"G9a promotes invasion and metastasis of non\u2013small cell lung cancer through enhancing focal adhesion kinase activation via NF-\u03baB signaling pathway","volume":"19","author":"Sun","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118113_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ccell.2018.09.001","article-title":"MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis","volume":"34","author":"Tu","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2025.118113_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1101\/gad.236794.113","article-title":"The methyltransferase G9a regulates HoxA9-dependent transcription in AML","volume":"28","author":"Lehnertz","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.ejmech.2025.118113_bib24","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/s41401-018-0205-5","article-title":"Inhibition of G9a by a small molecule inhibitor, UNC0642, induces apoptosis of human bladder cancer cells","volume":"40","author":"Cao","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2025.118113_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41591-019-0499-y","article-title":"Inhibition of a G9a\/DNMT network triggers immune-mediated bladder cancer regression","volume":"25","author":"Segovia","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2025.118113_bib26","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/s41388-020-01591-7","article-title":"G9a controls pluripotent-like identity and tumor-initiating function in human colorectal cancer","volume":"40","author":"Bergin","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2025.118113_bib27","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41419-018-0322-6","article-title":"G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner","volume":"9","author":"Hu","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118113_bib28","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ejmech.2019.06.072","article-title":"Recent progress in histone methyltransferase (G9a) inhibitors as anticancer agents","volume":"179","author":"Cao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15424","article-title":"Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies","volume":"8","author":"San Jos\u00e9-En\u00e9riz","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118113_bib30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1021\/cb500785t","article-title":"Chemical probes of histone lysine methyltransferases","volume":"10","author":"Kaniskan","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib31","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/jm501234a","article-title":"Selective inhibitors of protein methyltransferases","volume":"58","author":"Kaniskan","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/ml4002503","article-title":"Analogues of the natural product sinefungin as inhibitors of EHMT1 and EHMT2","volume":"5","author":"Devkota","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118113_bib33","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/cb300139y","article-title":"A small-molecule probe of the histone methyltransferase G9a induces cellular senescence in pancreatic adenocarcinoma","volume":"7","author":"Yuan","year":"2012","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib34","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.molcel.2007.01.017","article-title":"Reversal of H3K9me2 by a small-molecule inhibitor for the G9a histone methyltransferase","volume":"25","author":"Kubicek","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2025.118113_bib35","doi-asserted-by":"crossref","first-page":"7950","DOI":"10.1021\/jm901543m","article-title":"Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a","volume":"52","author":"Liu","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2010.04.048","article-title":"Adding a lysine mimic in the design of potent inhibitors of histone lysine methyltransferases","volume":"400","author":"Chang","year":"2010","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib37","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1021\/jm100478y","article-title":"Protein lysine methyltransferase G9a inhibitors: design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines","volume":"53","author":"Liu","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib38","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nchembio.599","article-title":"A chemical probe selectively inhibits G9a and GLP methyltransferase activity in cells","volume":"7","author":"Vedadi","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118113_bib39","doi-asserted-by":"crossref","first-page":"8931","DOI":"10.1021\/jm401480r","article-title":"Discovery of an in vivo chemical probe of the lysine methyltransferases G9a and GLP","volume":"56","author":"Liu","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib40","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1039\/C4MD00274A","article-title":"Identification of 2,4-diamino-6,7-dimethoxyquinoline derivatives as G9a inhibitors","volume":"5","author":"Srimongkolpithak","year":"2014","journal-title":"MedChemComm"},{"key":"10.1016\/j.ejmech.2025.118113_bib41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.30168","article-title":"Dual targeting of histone methyltransferase G9a and DNA-methyltransferase 1 for the treatment of experimental hepatocellular carcinoma","volume":"69","author":"B\u00e1rcena-Varela","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2025.118113_bib42","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1021\/acs.jmedchem.8b02008","article-title":"Discovery of a novel chemotype of histone lysine methyltransferase EHMT1\/2 (GLP\/G9a) inhibitors: rational design, synthesis, biological evaluation, and co-crystal structure","volume":"62","author":"Milite","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib43","doi-asserted-by":"crossref","first-page":"10506","DOI":"10.1021\/acs.jmedchem.2c00652","article-title":"Discovery of the first-in-class G9a\/GLP covalent inhibitors","volume":"65","author":"Park","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115841","article-title":"Discovery of novel G9a\/GLP covalent inhibitors for the treatment of triple-negative breast cancer","volume":"261","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib45","doi-asserted-by":"crossref","first-page":"8086","DOI":"10.1021\/acs.jmedchem.3c00411","article-title":"Structure-based design and characterization of the highly potent and selective covalent inhibitors targeting the lysine methyltransferases G9a\/GLP","volume":"66","author":"Feng","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1021\/ml400496h","article-title":"Discovery and development of potent and selective inhibitors of histone methyltransferase G9a","volume":"5","author":"Sweis","year":"2014","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2025.118113_bib47","series-title":"Amine-Substituted Aryl or Heteroaryl Compounds as EHMT1 and EHMT2 Inhibitors","year":"2017"},{"key":"10.1016\/j.ejmech.2025.118113_bib48","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1021\/acs.jmedchem.2c02059","article-title":"Discovery of novel substrate-competitive lysine methyltransferase G9a inhibitors as anticancer agents","volume":"66","author":"Nishigaya","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118113_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.34172\/bi.2021.23","article-title":"A sensitive homogeneous enzyme assay for euchromatic histone-lysine-N-methyltransferase 2 (G9a) based on terbium-to-quantum dot time-resolved FRET","volume":"11","author":"Amjadi","year":"2021","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ejmech.2025.118113_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cmet.2013.11.004","article-title":"The histone H3 methyltransferase G9a epigenetically activates the serine-glycine synthesis pathway to sustain cancer cell survival and proliferation","volume":"18","author":"Ding","year":"2013","journal-title":"Cell Metab."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425008785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:59:38Z","timestamp":1772830778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425008785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":50,"alternative-id":["S0223523425008785"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118113","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 2-tetrahydroisoquinoline substituted quinazoline derivatives as lysine methyltransferase G9a inhibitors with in vivo antitumor efficacy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118113","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118113"}}